Skip to Content
Merck
CN

F7806

3-Fluorobenzyl chloride

96%

Synonym(s):

α-Chloro-3-fluorotoluene, 1-Chloromethyl-3-fluorobenzene

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
FC6H4CH2Cl
CAS Number:
Molecular Weight:
144.57
EC Number:
207-264-8
UNSPSC Code:
12352100
PubChem Substance ID:
Beilstein/REAXYS Number:
742265
MDL number:
Assay:
96%
Form:
liquid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

XBDXMDVEZLOGMC-UHFFFAOYSA-N

InChI

1S/C7H6ClF/c8-5-6-2-1-3-7(9)4-6/h1-4H,5H2

SMILES string

Fc1cccc(CCl)c1

assay

96%

form

liquid

density

1.194 g/mL at 25 °C (lit.)

Looking for similar products? Visit Product Comparison Guide

pictograms

Corrosion

signalword

Danger

hcodes

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B

Storage Class

3 - Flammable liquids

wgk

WGK 3

flash_point_f

159.8 °F - closed cup

flash_point_c

71 °C - closed cup

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

William L Scott et al.
Journal of combinatorial chemistry, 11(1), 14-33 (2008-12-25)
Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computational stages of D(3) is the global rehearsal of prospective reagents and
Steffen Bugge et al.
European journal of medicinal chemistry, 94, 175-194 (2015-03-15)
An approach for optimization of epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors using truncated thienopyrimidine structures combined with enzymatic assay has been evaluated. This was done by synthesis and EGFR activity measurement of a series of fragment structures and
William L Scott et al.
Journal of combinatorial chemistry, 11(1), 34-43 (2008-12-25)
For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducibly make new, high quality, molecules with potential for biological activity. This article reports

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service